- Home
- AUPH vs THQ Comparison
AUPH vs THQ Comparison
Compare AUPH & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- THQ
- Stock Information
- Founded
- AUPH 1993
- THQ 2014
- Country
- AUPH Canada
- THQ United States
- Employees
- AUPH N/A
- THQ N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- THQ Finance Companies
- Sector
- AUPH Health Care
- THQ Finance
- Exchange
- AUPH Nasdaq
- THQ Nasdaq
- Market Cap
- AUPH 999.8M
- THQ 845.7M
- IPO Year
- AUPH 1999
- THQ N/A
- Fundamental
- Price
- AUPH $8.09
- THQ $18.70
- Analyst Decision
- AUPH Strong Buy
- THQ
- Analyst Count
- AUPH 2
- THQ 0
- Target Price
- AUPH $11.50
- THQ N/A
- AVG Volume (30 Days)
- AUPH 1.3M
- THQ 158.9K
- Earning Date
- AUPH 05-05-2025
- THQ 01-01-0001
- Dividend Yield
- AUPH N/A
- THQ 7.53%
- EPS Growth
- AUPH N/A
- THQ N/A
- EPS
- AUPH 0.04
- THQ N/A
- Revenue
- AUPH $235,133,000.00
- THQ N/A
- Revenue This Year
- AUPH $11.86
- THQ N/A
- Revenue Next Year
- AUPH $24.96
- THQ N/A
- P/E Ratio
- AUPH $197.25
- THQ N/A
- Revenue Growth
- AUPH 33.97
- THQ N/A
- 52 Week Low
- AUPH $4.77
- THQ $15.29
- 52 Week High
- AUPH $10.67
- THQ $20.38
- Technical
- Relative Strength Index (RSI)
- AUPH 54.42
- THQ 40.83
- Support Level
- AUPH $7.59
- THQ $18.33
- Resistance Level
- AUPH $7.83
- THQ $19.50
- Average True Range (ATR)
- AUPH 0.34
- THQ 0.73
- MACD
- AUPH 0.04
- THQ -0.01
- Stochastic Oscillator
- AUPH 84.90
- THQ 41.56
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About THQ abrdn Healthcare Opportunities Fund Shares of Beneficial Interest
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies.